Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medicinova (MNOV) EBT (2021 - 2025)

Medicinova (MNOV) has disclosed EBT for 7 consecutive years, with $7.3 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT changed N/A to $7.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.6 million, a N/A change, with the full-year FY2025 number at $12821.0, up 100.12% from a year prior.
  • EBT was $7.3 million for Q4 2025 at Medicinova, up from -$3.4 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $7.3 million in Q4 2025 to a low of -$3.6 million in Q2 2025.
  • A 5-year average of -$1.1 million and a median of -$2.8 million in 2023 define the central range for EBT.
  • Peak YoY movement for EBT: crashed 1945.77% in 2022, then rose 27.23% in 2023.
  • Medicinova's EBT stood at $6.8 million in 2021, then tumbled by 149.42% to -$3.4 million in 2022, then surged by 69.23% to -$1.0 million in 2023, then tumbled by 175.7% to -$2.9 million in 2024, then soared by 354.26% to $7.3 million in 2025.
  • Per Business Quant, the three most recent readings for MNOV's EBT are $7.3 million (Q4 2025), -$3.4 million (Q3 2025), and -$3.6 million (Q2 2025).